MSB 2.10% $1.17 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-355

  1. 1,044 Posts.
    lightbulb Created with Sketch. 1110
    I agree there's an inconsistency there, and my argument is that it's due to the nature of the treatment, rather than a conspiracy. Requiring the novel MSC treatment to do more proof than just another injection, pill or chemical compound that has more history, known biomarkers etc.

    Fear of the unknown, basically...
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.